Shenyang Northern Hospital Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2012
NCT01721590
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Han Yaling | Qiang Hu

Active Ingredients

Drugs in Phase 4 Trials (3)

omeprazole (prilosec) (1 trial)

pantoprazole (protonix) (1 trial)

tongxinluo (1 trial)

Drugs in Other Trials (1)

nicotinamide (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Coronary Syndrome (Phase 4)

Coronary Artery Disease (Phase 4)

Coronary Disease (Phase 4)

Heart Diseases (Phase 4)

Myocardial Ischemia (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 4